Gemma Brown - Feb 3, 2025 Form 4 Insider Report for Barinthus Biotherapeutics plc. (BRNS)

Role
Chief Financial Officer
Signature
/s/ William Enright, Attorney-in-Fact
Stock symbol
BRNS
Transactions as of
Feb 3, 2025
Transactions value $
$0
Form type
4
Date filed
2/5/2025, 04:24 PM
Previous filing
Jan 4, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRNS Share Option (Right to Buy) Award $0 +160K $0.00 160K Feb 3, 2025 Ordinary Shares 160K $1.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on February 3, 2026.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.